David Bailey

Stock Analyst at Morgan Stanley

(3.83)
# 1,954
Out of 5,134 analysts
240
Total ratings
47.6%
Success rate
7.3%
Average return

Stocks Rated by David Bailey

Cochlear Limited
Nov 16, 2026
Reiterated: Hold
Price Target: $133.00
Current: $151.44
Upside: -12.18%
ResMed Inc.
Nov 10, 2026
Reiterated: Hold
Price Target: n/a
Current: $35.51
Upside: -
Ramsay Health Care Limited
Nov 8, 2026
Reiterated: Sell
Price Target: $41.90
Current: $53.60
Upside: -21.83%
CSL Limited
Nov 4, 2026
Reiterated: Buy
Price Target: $200.00
Current: $198.51
Upside: +0.75%
Integral Diagnostics Limited
Oct 30, 2026
Reiterated: Buy
Price Target: $3.70 → $3.00
Current: $1.61
Upside: +86.05%
ResMed
Oct 30, 2026
Reiterated: Hold
Price Target: $230 → $233
Current: $238.19
Upside: -2.18%
Telix Pharmaceuticals Limited
Sep 15, 2026
Reiterated: Buy
Price Target: $23.90
Current: $13.19
Upside: +81.20%
Sonic Healthcare Limited
Sep 1, 2026
Reiterated: Sell
Price Target: $20.60 → $20.30
Current: $19.82
Upside: +2.42%
Ansell Limited
Aug 31, 2026
Reiterated: Hold
Price Target: $32.70 → $37.90
Current: $46.19
Upside: -17.95%
Fisher & Paykel Healthcare Corporation Limited
Aug 24, 2026
Reiterated: Buy
Price Target: n/a
Current: $48.23
Upside: -
Reiterated: Buy
Price Target: $127.50 → $152.50
Current: $198.48
Upside: n/a
Reiterated: Hold
Price Target: $1.50 → $1.35
Current: $0.59
Upside: n/a
Reiterated: Buy
Price Target: $3.05 → $3.55
Current: $5.10
Upside: n/a
Reiterated: Hold
Price Target: n/a
Current: $13.39
Upside: n/a
Reiterated: Hold
Price Target: $0.36
Current: $5.83
Upside: n/a
Downgraded: Hold
Price Target: $2.75
Current: $0.87
Upside: n/a